Home - Products - Others - Other Targets - [Ala4] - MBP (1 - 11)

[Ala4] - MBP (1 - 11)

CAS No. ———

[Ala4] - MBP (1 - 11)( ——— )

Catalog No. M41366 CAS No. ———

[Ala4] - MBP (1 - 11)

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	Get Quote	Get Quote
50MG	Get Quote	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

[Ala4] - MBP (1 - 11)
Note

Research use only, not for human use.
Brief Description

[Ala4] - MBP (1 - 11)
Description

[Ala4] - MBP (1 - 11)
In Vitro

———
In Vivo

———
Synonyms

———
Pathway

Others
Target

Other Targets
Recptor

———
Research Area

———
Indication

———

Chemical Information

CAS Number

———
Formula Weight

1236.32
Molecular Formula

C49H81N21O17
Purity

>98% (HPLC)
Solubility

———
SMILES

———
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

UDP-?glucuronic acid...

UDP-?glucuronic acid trisodium is a critical precursor for essential glycoconjugates across biological kingdoms, ranging from mammalian glycosaminoglycans and plant cell wall polysaccharides to bacterial capsule glycoglycerolipids.
Rozanolixizumab

Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
Rhamnazin

Rhamnazin is an orally active inhibitor of VEGFR2 signaling with an IC50 of 4.68 μM against VEGFR2 kinase. Rhamnazin shows potent antiangiogenic activity and antitumor efficacy. Rhamnazin shows antioxidant and anti-inflammatory properties.

Sign In Join Free